Skip to main content

. 1986 Nov 29;293(6559):1407. doi: 10.1136/bmj.293.6559.1407

Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.

P J Prouse, D Shawe, J M Gumpel

PMCID: PMC1342172 PMID: 2879599

1407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Das K. M., Eastwood M. A., McManus J. P., Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med. 1973 Sep 6;289(10):491–495. doi: 10.1056/NEJM197309062891001. [DOI] [PubMed] [Google Scholar]
Grindulis K. A., McConkey B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis? Scand J Rheumatol. 1985;14(3):265–270. doi: 10.3109/03009748509100404. [DOI] [PubMed] [Google Scholar]
Longstreth G. F., Green R. Folate status in patients receiving maintenance doses of sulfasalazine. Arch Intern Med. 1983 May;143(5):902–904. [PubMed] [Google Scholar]
McConkey B., Amos R. S., Durham S., Forster P. J., Hubball S., Walsh L. Sulphasalazine in rheumatoid arthritis. Br Med J. 1980 Feb 16;280(6212):442–444. doi: 10.1136/bmj.280.6212.442. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES